Showing results (2661-2670 of 6,740) with videos related to
Sort By:
Pageof 674
Oncotargets and Therapy|July 20, 2017
Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patientsAneta Cymbaluk-Płoska, Anita Chudecka-Głaz, Ewa Pius-Sadowska, et al.Oncotargets and Therapy|July 20, 2017
Patients harboring ALK rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case reportYou-Cai Zhu, Xing-Hui Liao, Wen-Xian Wang, et al.Oncotargets and Therapy|July 20, 2017
Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunctionMidori Shimada, Minoru Fukuda, Masaaki Fukuda, et al.Oncotargets and Therapy|July 20, 2017
LincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through miR-9/E-cadherin cascade signaling pathway molecular mechanismGangqiang Ding, Zhen Peng, Jia Shang, et al.Oncotargets and Therapy|May 14, 2016
Diagnostic value of BRAF (V600E)-mutation analysis in fine-needle aspiration of thyroid nodules: a meta-analysisXingyun Su, Xiaoxia Jiang, Xin Xu, et al.Oncotargets and Therapy|June 11, 2016
miR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinomaChengxia Liu, Ming Li, Yingbin Hu, et al.Oncotargets and Therapy|June 11, 2016
Integrated miRNA-risk gene-pathway pair network analysis provides prognostic biomarkers for gastric cancerHui Cai, Jiping Xu, Yifang Han, et al.Oncotargets and Therapy|June 11, 2016
Association between cooking oil fume exposure and lung cancer among Chinese nonsmoking women: a meta-analysisYingbo Xue, Ying Jiang, Shan Jin, et al.Oncotargets and Therapy|June 11, 2016
Prognostic value of the standardized uptake value maximum change calculated by dual-time-point (18)F-fluorodeoxyglucose positron emission tomography imaging in patients with advanced non-small-cell lung cancerFeng Jin, Hui Zhu, Zheng Fu, et al.Pageof 674